Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-013869
Filing Date
2019-02-26
Accepted
2019-02-26 20:37:54
Documents
2
Period of Report
2019-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11086
2 POA DOCUMENT poa.txt EX-24.3_836884 3043
  Complete submission text file 0001209191-19-013869.txt   15636
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Issuer) CIK: 0001492426 (see all company filings)

EIN.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HORIZON PHARMA PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4
Business Address
Kent Jeff (Reporting) CIK: 0001769107 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35238 | Film No.: 19635488